INDUCED CONFORMATIONS OF BIOLOGICALLY ACTIVE PEPTIDES
INDUCED CONFORMATIONS OF BIOLOGICALLY ACTIVE PEPTIDES
批准号:
2183271
负责人:
SYLVIE E BLONDELLE
金额:
$11.12万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-04-01 至 1996-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of the proposed research is to study induced conformations
resulting from peptide/lipid and peptide/peptide interactions. This will
be accomplished by studying the perturbations of induced conformations
using reversed-phase high-performance liquid chromatography (RP-HPLC) in
conjunction with circular dichroism (CD). An essential element in our
approach involves the systematic design and synthesis of complete series
of related peptides in which only one variable in the starting parent
sequence will be altered at a given time (i.e. , a single amino acid
omitted, inserted, substituted, etc.) . The results for all of the
peptides studied will be then correlated with their biological
activities, such as antimicrobial activity, and/or red blood cell lysis.
The dominant causative factor responsible for the biological activity of
peptides is believed to be their induced secondary structures at their
specific sites of action. Although peptides virtually always exert their
functional activity at biological interfaces, the specific secondary
structures into which they are induced at such interfaces cannot be
readily determined. Technological improvements in NMR and X-ray
crystallography enable conformational studies of this kind to be carried
out, but these technologies are time-consuming and limited to those
laboratories with the required physical and computing facilities.
Therefore, we will study the relative induced secondary structures of
specific peptide series as determined by variation of their RP-HPLC
retention times. In this way, we expect to be able to assess the
potential general usefulness of RP-HPLC as a system modeling biologically
relevant aqueous/lipid interfaces. The simplicity and availability of
RP-HPLC will enable the majority of laboratories to take advantage of our
current and future results. As a complementary approach, synthetic
combinatorial peptide libraries, comprised of tens of millions of
peptides, will be used to study melittin's sites of interaction with red
blood cell membranes. These approaches are expected to have a
significant impact on the understanding of peptide interactions in the
fields of immunology, molecular biology, and microbiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunogenic epitopes of rare HIV mutants as vaccines
-
批准号:7124995
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2005
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
Immunogenic epitopes of rare HIV mutants as vaccines
-
批准号:7004892
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2005
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
Novel KSHV-specific CTL epitopes for development
-
批准号:6594865
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2002
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
Novel KSHV-specific CTL epitopes for development
-
批准号:6652579
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2002
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
OPTIMIZED HIV -SPECIFIC CTL ANTIGENS FOR VACCINE DESIGN
-
批准号:6312310
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2001
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
OPTIMIZED HIV -SPECIFIC CTL ANTIGENS FOR VACCINE DESIGN
-
批准号:6511432
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2001
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
HIGH AFFINITY AGONISTS OF HIV1 DEPENDENT FUSION
-
批准号:6350603
-
项目类别:
-
资助金额:$23.43万
-
财政年份:1999
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
HIGH AFFINITY AGONISTS OF HIV1 DEPENDENT FUSION
-
批准号:2758972
-
项目类别:
-
资助金额:$22.08万
-
财政年份:1999
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
HIGH AFFINITY AGONISTS OF HIV1 DEPENDENT FUSION
-
批准号:6150544
-
项目类别:
-
资助金额:$22.75万
-
财政年份:1999
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
MODEL SYSTEMS FOR BETA AMYLOID FORMATION AND INHIBITION
-
批准号:2500991
-
项目类别:
-
资助金额:$8.39万
-
财政年份:1997
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
INDUCED CONFORMATIONS OF BIOLOGICALLY ACTIVE PEPTIDES
-
批准号:2183272
-
项目类别:
-
资助金额:$11.57万
-
财政年份:1993
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
INDUCED CONFORMATIONS OF BIOLOGICALLY ACTIVE PEPTIDES
-
批准号:3305023
-
项目类别:
-
资助金额:$10.7万
-
财政年份:1993
-
负责人:SYLVIE E BLONDELLE
-
依托单位:
海外基金